<DOC>
	<DOC>NCT00698230</DOC>
	<brief_summary>Determine the effect of treatment with INCB013739 administered as an 'add-on' to metformin therapy in type 2 diabetic subjects on safety and tolerability and glycemic control.</brief_summary>
	<brief_title>Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 Diabetics</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<criteria>Established diagnosis of Type 2 Diabetes Stable dose of metformin for more than 8 weeks Subjects with Addison's disease or Cushing's Syndrome Type 1 diabetes mellitus or secondary forms of diabetes Subjects with uncontrolled thyroid disease History of renal impairment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>